Chemical Structure (Image 1)
Finasteride
Product Images NDC 67296-2056
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 67296-2056). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 Symptom Score In Long-term Efficacy And Safety Study (Image 2)
Figure 2 Percent Of Patients Having Surgery For Bph, Including Turp (Image 3)
This is a description of data related to two groups: Finasteride Group and Placebo. The data includes the number of events and cumulative events for each group. The Placebo group has a cumulative count of 57 and the Finasteride group has a cumulative count of 18 events. Additionally, the number of risk person-years is provided for each group.*
Figure 4 (Image 4)
This text provides the mean percent change from baseline with standard error (SE) for two groups: Placebo and Finasteride. The data includes the number of participants in each group at the baseline, Year 1, Year 2, and subsequent years. The percentage change in values over time is shown for both groups.*
Figure 5 (Image 5)
This is a graph showing the cumulative incidence of a 4 point rise in AUA Symptom Score by treatment group over several years since randomization. The data is represented by percentages.*
Label 5 mg, 500 Tablets (Image 6)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
